EXPO (Exponent) Risk Assessment


EXPO Exponent Inc EXPO
83 GF Score
Price $61.18
GF Value $92.48
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Exponent Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Exponent is: Low Risk: Strong fundamentals, worth long-term holding.


Exponent  (NAS:EXPO) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Exponent Risk Assessment Related Terms


EXPO vs CDNL, TPC, KBR: Risk Assessment Comparison

For the Engineering & Construction subindustry, Exponent's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exponent Risk Assessment vs Construction Industry

For the Construction industry and Industrials sector, Exponent's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Exponent's Risk Assessment falls into.


EXPO
83GF Score
Exponent Inc EXPO
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Exponent (EXPO) Overvalued in 2026?

Based on GuruFocus' analysis, Exponent stock appears to be undervalued. The current stock price of $61.18 is trading 33.8% below its estimated GF Value™ of $92.48. GuruFocus considers Exponent to be Significantly Undervalued.

Key valuation signals for EXPO:

  • Risk Assessment:
  • GF Value™: $92.48 vs. price of $61.18 (33.8% below fair value)
  • GF Score™: 83/100 with 3 warning signs

No single metric tells the full story. See the EXPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Exponent Business Description

Other Exchanges EP5:Germany
Address 149 Commonwealth Drive, Menlo Park, CA, USA, 94025
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
83GF Score

Get the complete analysis for EXPO

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$61.18
Price
$92.48
GF Value